Stockreport

Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF This compares to loss of $2.97 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.68% [Read more]